Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Targeting cytokines in inflammatory bowel disease. (2022) Neurath M Journal article, Review article Transabdominal ultrasonography for confirmation of accurate percutaneous endoscopic gastrostomy tube placement: analysis of patient- and procedure-related complications (2022) Wildner D, Pfeifer L, Vitali F, Neurath M, Albrecht H Journal article Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease (2022) Schneider I, Allner C, Mühl L, Melde M, Lissner D, Mantzivi E, Glauben R, et al. Journal article Cetuximab-Induced Aseptic Meningitis in a Patient with Colorectal Cancer: A Case Report and Review of Literature (2022) Jäger J, Sprügel M, Brunner T, Uhl M, Schwab S, Vitali F, Wein A, Volbers B Journal article, Review article Endocytoscopy for assessing histologic inflammation in ulcerative colitis: development and prospective validation of the ELECT (ErLangen Endocytoscopy in ColiTis) score (with videos) (2022) Vitali F, Morgenstern N, Eckstein M, Atreya R, Waldner M, Hartmann A, Neurath M, Rath T Journal article Macrophages inhibit Coxiella burnetii by the ACOD1-itaconate pathway for containment of Q fever (2022) Kohl L, Siddique MNAA, Bodendorfer B, Berger R, Preikschat A, Daniel C, Ölke M, et al. Journal article Biomimetic Magnetic Particles for the Removal of Gram-Positive Bacteria and Lipoteichoic Acid. (2022) Friedrich B, Eichermüller J, Bogdan C, Cunningham S, Hackstein H, Strauss R, Alexiou C, et al. Journal article Streptozotocin, 1982-2022: Forty Years from the FDA's Approval to Treat Pancreatic Neuroendocrine Tumors (2022) Capdevila J, Ducreux M, García Carbonero R, Grande E, Halfdanarson T, Pavel ME, Tafuto S, et al. Journal article, Review article Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial (2022) Sandborn WJ, Panés J, Danese S, Sharafali Z, Hassanali A, Jacob-Moffatt R, Eden C, et al. Journal article IL-4/IL-13-producing ILC2s are required for timely control of intestinal helminth infection in mice (2022) Varela F, Symowski C, Pollock J, Wirtz S, Vöhringer D Journal article